Where no synapses go: Gatekeepers of circuit remodeling and synaptic strength

Yevgeniya A. Mironova, Roman J. Giger

Research output: Contribution to journalReview articlepeer-review


Growth inhibitory molecules in the adult mammalian central nervous system (CNS) have been implicated in the blocking of axonal sprouting and regeneration following injury. Prominent CNS regeneration inhibitors include Nogo-A, oligodendrocyte myelin glycoprotein (OMgp), and chondroitin sulfate proteoglycans (CSPGs), and a key question concerns their physiological role in the naïve CNS. Emerging evidence suggests novel functions in dendrites and at synapses of glutamatergic neurons. CNS regeneration inhibitors target the neuronal actin cytoskeleton to regulate dendritic spine maturation, long-term synapse stability, and Hebbian forms of synaptic plasticity. This is accomplished in part by antagonizing plasticity-promoting signaling pathways activated by neurotrophic factors. Altered function of CNS regeneration inhibitors is associated with mental illness and loss of long-lasting memory, suggesting unexpected and novel physiological roles for these molecules in brain health.

Original languageEnglish (US)
Pages (from-to)363-373
Number of pages11
JournalTrends in neurosciences
Issue number6
StatePublished - Jun 2013
Externally publishedYes


  • Dendritic spine
  • Nogo receptor
  • Nogo-A
  • Oligodendrocyte myelin glycoprotein (OMgp)
  • Proteoglycan
  • Synapse stability
  • Synaptic structure

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Where no synapses go: Gatekeepers of circuit remodeling and synaptic strength'. Together they form a unique fingerprint.

Cite this